GlassScriptPhysician profile
Ramona Kiani
NPI 1861843765
$2,250.74
in general payments reported to CMS, 2019-2025
18 companies · $653 in 2025
The $653 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $478 · 2023: $331 · 2024: $429 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.78 |
| Education | $276.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,118.34 | 2021-2025 | |
| Janssen Biotech, INC. | $400.61 | 2022-2025 | Tremfya, Simponi, Stelara |
| Novartis Pharmaceuticals Corporation | $112.13 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $104.31 | 2024-2025 | Dupixent, Libtayo |
| Pfizer INC. | $99.19 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $83.39 | 2021-2025 | |
| Kyowa Kirin, INC. | $52.06 | 2025 | |
| Lilly USA, LLC | $48.51 | 2022-2025 | Ebglyss, Taltz |
| Galderma Laboratories, L.P. | $45.25 | 2024-2025 | Nemluvio, Aklief |
| Ucb, INC. | $42.34 | 2023-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $32.88 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $21.61 | 2022 | |
| Organon LLC | $20.75 | 2025 | Vtama |
| Botanix Sb INC | $19.98 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $15.47 | 2023 | Vtama |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $13.87 | 2025 | Zoryve |
| Incyte Corporation | $13.02 | 2022 | |
| Mayne Pharma Commercial LLC | $7.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramona Kiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.